Snisarenko John 4
4 · Oyster Point Pharma, Inc. · Filed Nov 5, 2019
Insider Transaction Report
Form 4
Snisarenko John
Chief Commercial Officer
Transactions
- Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+3,000$48,000→ 3,000 total